Summary
Mortality from cancer among 178 parents and 236 grandparents of 95 British patients with ataxia-telangiectasia was examined. For neither parents nor grandparents was mortality from all causes or from cancer appreciably elevated over that of the national population. Among mothers, three deaths from breast cancer gave rise to a standardized mortality ratio of 3.37 (95% confidence interval (CI): 0.69–9.84). In contrast, there was no excess of breast cancer in grandmothers, the standardized mortality ratio being 0.89 (95% CI: 0.18–2.59), based on three deaths. This is the largest study of families of ataxia-telangiectasia patients conducted in Britain but, nonetheless, the study is small and CIs are wide. However, taken together with data from other countries, an increased risk of breast cancer among female heterozygotes is still apparent, though lower than previously thought.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Athma, P., Rappaport, R. & Swift, M. (1996). Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92: 130–134.
Bishop, D. T. & Hopper, J. (1997). AT-tributable risks? Nat Genet 15: –226.
Borresen, A. L., Anderson, T. L., Treti, S., Heiberg, A. & Moller, P. (1990). Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosom Cancer 2: 339–340.
Breslow, N. E. & Day, N. E. (1987). Statistical Methods in Cancer Research, Vol 2. The Design and Analysis of Cohort Studies, International Agency for Research on Cancer: Lyon
Bridges, B. & Arlett, C. (1992). Risk of breast cancer in ataxia-telangiectasia. N Engl J Med 326: 1357
Easton, D. F. (1994). Cancer risks in A-T heterozygotes. Int J Radiat Biol 6: S177–S182.
Fitzgerald, M. G., Bean, J. M., Hegde, S. R., Unsal, H., MacDonald, D. J., Harkin, D. P., Finkelstein, D. M., Isselbacher, K. J. & Haber, D. A. (1997). Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 15: 307–310.
Pippard, E. C., Hall, A. J., Barker, D. J. P. & Bridges, B. A. (1988). Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 48: 2929–2932.
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N. G. J., Taylor, A. M. R., Arlett, C. F., Miki, T., Weissman, S. M., Lovett, M., Collins, F. S. & Shiloh, Y. (1995). A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749–1753.
Stilgenbauer, S., Schaffner, C., Litterst, A., Liebisch, P., Gilad, S., Bar-Shira, A., James, M. R., Lichter, P. & Dohner, H. (1997). Biallelic mutations in the ATM gene in T-prolymphocytic leukaemia. Nat Med 3: 1155–1160.
Stoppa-Lyonnet, D., Soulier, J., Lauge, A., Dastot, H., Garand, R., Sigaux, F. & Stern, M. H. (1998). Inactivations of the ATM gene in T cell prolymphocytic leukaemia. Blood 91: 3920–3926.
Swift, M., Reitnauer, P. J., Morrell, D. & Chase, C. L. (1987). Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316: 1289–1294.
Swift, M., Morrell, D., Massey, R. B. & Chase, C. L. (1991). Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Eng J Med 325: 1831–1836.
Vorechovsky, I., Luo, L., Dyer, M. J. S., Catovsky, D., Amlot, P., Yaxley, J. C., Foroni, L., Hammarstrom, L., Webster, A. D. B. & Yuille, M. A. R. (1997). Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T cell leukaemia. Nat Genet 17: 96–99.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Inskip, H., Kinlen, L., Taylor, A. et al. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia. Br J Cancer 79, 1304–1307 (1999). https://doi.org/10.1038/sj.bjc.6690209
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690209
Keywords
This article is cited by
-
First international workshop of the ATM and cancer risk group (4-5 December 2019)
Familial Cancer (2022)
-
The association between ATM variants and risk of breast cancer: a systematic review and meta-analysis
BMC Cancer (2021)
-
Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia
British Journal of Cancer (2012)
-
Association between ATM 5557G>A polymorphism and breast cancer risk: a meta-analysis
Molecular Biology Reports (2012)
-
Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls
Breast Cancer Research and Treatment (2011)